2026 Breakthrough T1D Illinois Chapter Annual Meeting

You are cordially invited to the 2026 Breakthrough T1D Illinois Chapter Annual Meeting.

Join us for an extraordinary occasion sharing our mission progress and celebrating the cumulative impact of Breakthrough T1D Illinois’ donors and volunteers over the past fiscal year.

Together, we have delivered on substantial projects and driven truly incredible research that is getting us closer to cures and is improving the lives of everyone impacted by type 1 diabetes (T1D).

Joining us will be Piotr Witkowski, M.D., Ph.D., of the University of Chicago School of Medicine. Dr. Witkowski is a transplant surgeon and Professor of Surgery at UChicago Medicine, where he directs the Pancreatic and Islet Transplant Program. His work includes Vertex’s manufactured islet therapy, Zimislecel, and Eledon’s novel immunosuppressive approach, Tegoprubart, both of which have demonstrated promising early results.

Dr. Witkowski is a lead investigator in groundbreaking clinical trials, including Vertex’s stem cell–derived islet therapy (VX-880) and Eledon’s novel immunosuppressive approach (Tegoprubart), both of which have shown promising early results. His work is helping move the field closer to a functional cure for T1D.

All guests are invited to join us for a celebratory reception with beer, wine, and light hors d’oeuvres following the meeting.

Schedule of Events:

5:00 p.m. – Registration

5:30 p.m. – Meeting Begins

Reception to follow